SI
PAHC icon

Sofinnova Investments’s Phibro Animal Health PAHC Stock Holding History

Sofinnova Investments’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-238,184
Closed -$5.36M – 73
2024
Q3 		$5.36M Buy
238,184
+1,175
+0.5% +$22.7K 0.43% 41
2024
Q2 		$3.97M Buy
+237,009
New +$3.81M 0.21% 59

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sofinnova Investments's PAHC Position: Q4 2024 in Review

Sofinnova Investments sold out of Phibro Animal Health (PAHC) in Q4 2024, closing a stake of 238,184 shares — an estimated $5.36M sold.

Sofinnova Investments first reported a position in PAHC in Q2 2024 and held it in 2 quarters. The position peaked at $5.36M in Q3 2024. 172 funds tracked by Wall St. Rank hold PAHC as of Q4 2024.

  • Sofinnova Investments reported no remaining Phibro Animal Health position as of Q4 2024 after selling out during the quarter.
  • Sofinnova Investments sold 238,184 Phibro Animal Health shares in Q4 2024, an estimated $5.36M.
  • Sofinnova Investments first reported a position in Phibro Animal Health in Q2 2024 and held it in 2 quarters.
  • Sofinnova Investments's Phibro Animal Health position peaked at $5.36M in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2024.

Based on Sofinnova Investments's 13F filing for Q4 2024, filed 14 Feb 2025.